Dr. Nabil M Yazgi , MD, PA
Specialist • Wayne, NJ
401 Hamburg Tpke Ste 102
Wayne, NJ 074702139
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 25, 2006; this date does not establish years in practice.
-
Published CMS data list 176 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 128 service units.
- 99215 — Established patient outpatient office visit: 34 service units.
- 99205 — New patient outpatient office visit: 14 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,679 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Oxycodone Hcl — 422 prescription fills, including refills.
- Gabapentin — 98 prescription fills, including refills.
- Alprazolam — 85 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 55 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 85% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: 1,216. Middle half: 379 to 3,335.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 361 in 2020 to 176 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
401 Hamburg Tpke Ste 102
Wayne, NJ 074702139
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
1979
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
56 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $25,441 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $18,667 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,964 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$437,119 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,501.69 across 95 records.
By nature of payment
- Food and Beverage: $1,501.69 across 95 records.
Reporting-company totals (3 largest of 17)
- Pfizer Inc.: $259.32 across 21 records.
- ABBVIE INC.: $259.01 across 16 records.
- Novartis Pharmaceuticals Corporation: $220.16 across 15 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
47 years (graduated 1979)
CMS Doctors and Clinicians data list 1979 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Yazgi has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Yazgi as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Wayne and New Jersey
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 85% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: 1,216. Middle half: 379 to 3,335.
Too few clinicians listed under Specialist in Wayne have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A lower Medicare-allowed amount than 75% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: $102,518. Middle half: $34,749 to $219,553.
Too few clinicians listed under Specialist in Wayne have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 80% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: $77,614. Middle half: $27,413 to $166,417.
Too few clinicians listed under Specialist in Wayne have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Specialist in New Jersey (2024, 365 clinicians with data). Median for this group: 645. Middle half: 134 to 1,745.
Too few clinicians listed under Specialist in Wayne have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Specialist in New Jersey (2024, 365 clinicians with data). Median for this group: $63,715. Middle half: $4,163 to $333,079.
Too few clinicians listed under Specialist in Wayne have Medicare Part D data for 2024 to compare.
25 active clinicians are listed under Specialist with a practice address in Wayne, NJ (1,641 in New Jersey).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Wayne
12% of these 25 clinicians have the CMS telehealth indicator.
32% of these 25 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 51% from 361 in 2020 to 176 in 2024.
- 2020: 361
- 2021: 286
- 2022: 264
- 2023: 322
- 2024: 176
-
Medicare-allowed amount
Medicare-allowed amount decreased 50% from $50,839 in 2020 to $25,441 in 2024.
- 2020: $50,839
- 2021: $43,464
- 2022: $40,220
- 2023: $50,242
- 2024: $25,441
-
Paid by Medicare
Paid by Medicare decreased 50% from $37,583 in 2020 to $18,667 in 2024.
- 2020: $37,583
- 2021: $32,220
- 2022: $30,195
- 2023: $37,616
- 2024: $18,667
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 13% from 1,929 in 2020 to 1,679 in 2024.
- 2020: 1,929
- 2021: 1,846
- 2022: 1,726
- 2023: 1,811
- 2024: 1,679
-
30-day fills
30-day fills decreased 12% from 2,226 in 2020 to 1,964 in 2024.
- 2020: 2,226
- 2021: 2,134
- 2022: 1,976
- 2023: 2,109
- 2024: 1,964
-
Part D drug cost
Part D drug cost decreased 24% from $575,719 in 2020 to $437,119 in 2024.
- 2020: $575,719
- 2021: $438,640
- 2022: $419,495
- 2023: $324,141
- 2024: $437,119
-
Industry payments (Open Payments)
Industry payments (Open Payments) stayed about the same: $1,538.06 in 2021 and $1,501.69 in 2025.
- 2021: $1,538.06
- 2022: $1,625.81
- 2023: $1,316.99
- 2024: $1,611.66
- 2025: $1,501.69
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 95 records totaling $1,501.69.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KESIMPTA | General | $28.22 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KESIMPTA | General | $26.88 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KESIMPTA | General | $25.40 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Nayzilam | General | $23.95 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KESIMPTA | General | $23.04 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KESIMPTA | General | $22.62 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
KISUNLA | General | $22.54 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $22.04 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Briviact | General | $21.95 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $21.25 |
| ARGENX US, INC. |
Food and Beverage
In-kind items and services
|
VYVGART HYTRULO | General | $20.73 |
| ARGENX US, INC. |
Food and Beverage
In-kind items and services
|
VYVGART HYTRULO | General | $19.98 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $19.92 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KESIMPTA | General | $19.80 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
KISUNLA | General | $19.62 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $19.42 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
KISUNLA | General | $19.39 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KESIMPTA | General | $19.27 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $19.26 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
KISUNLA | General | $19.25 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ZAVZPRET | General | $19.21 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
KISUNLA | General | $19.17 |
| Eisai Inc. |
Food and Beverage
In-kind items and services
|
Leqembi | General | $19.11 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
ZEPOSIA | General | $19.05 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
NURTEC ODT | General | $18.98 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
128 | 33 | $130.00 | $128.07 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
34 | 19 | $170.00 | $167.54 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
14 | 14 | $300.00 | $239.41 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Oxycodone Hcl | Oxycodone Hcl | 422 | 10,296 | $17,229.96 | 41 |
| Gabapentin | Gabapentin | 98 | 3,930 | $1,668.87 | 15 |
| Alprazolam | Alprazolam | 85 | 2,497 | $456.38 | — |
| Diclofenac Sodium | Diclofenac Sodium | 65 | 1,913 | $12,052.94 | 11 |
| Donepezil Hcl | Donepezil Hcl | 51 | 2,550 | $227.49 | 12 |
| Memantine Hcl | Memantine Hcl | 39 | 2,310 | $798.76 | 12 |
| Diazepam | Diazepam | 37 | 816 | $256.50 | — |
| Methadone Hcl | Methadone Hcl | 34 | 964 | $2,455.78 | — |
| Fentanyl | Fentanyl | 33 | 990 | $8,384.52 | — |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 33 | 581 | $977.72 | — |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 32 | 488 | $295.41 | — |
| Topiramate | Topiramate | 29 | 1,110 | $156.93 | — |
| Tramadol Hcl | Tramadol Hcl | 29 | 300 | $80.63 | — |
| Sumatriptan Succinate | Sumatriptan Succinate | 29 | 1,085 | $6,973.70 | — |
| Zolpidem Tartrate | Zolpidem Tartrate | 27 | 1,050 | $75.00 | — |
| Botox | Onabotulinumtoxina | 27 | 1,998 | $42,474.66 | — |
| Tizanidine Hcl | Tizanidine Hcl | 26 | 780 | $154.95 | — |
| Oxycontin | Oxycodone Hcl | 25 | 733 | $25,738.16 | — |
| Rytary | Carbidopa/Levodopa | 25 | 856 | $18,070.28 | — |
| Ztlido | Lidocaine | 25 | 690 | $8,104.31 | — |
| Nortriptyline Hcl | Nortriptyline Hcl | 24 | 689 | $282.44 | — |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 22 | 660 | $732.96 | — |
| Pregabalin | Pregabalin | 22 | 765 | $408.93 | — |
| Levetiracetam | Levetiracetam | 21 | 1,900 | $476.28 | — |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 21 | 339 | $435.17 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEUROLOGY
I20081006000104
NJ
1052498813
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History
NPI enumerated August 25, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Specialists in Wayne
- Dr. Nina Mohammed, MD
- Dr. Sheila Newman, MD
- Dr. Robert Bazzini, MD
- Dr. Manizheh Panah, MD
- Dr. Nadereh Behnam, MD
- Dr. Mark Ruoff, MD
Mailing Address
401 Hamburg Tpke Ste 102
Wayne, NJ 074702139
Phone: 9737901180